Additionally, it has also been reported that an RXR agonist, AGN194204, potentiated the anti-proliferative and pro-apoptotic responses of breast cancer cell lines to PPAR agonists through RXR-PPAR heterodimer [44]. The gene discussed is PPARA; the disease is breast cancer.